Peng Zhaoqiang

Zhejiang Rongyao Biotechnology Co., Ltd. is located in the Taizhou Bay Economic and Technological Development Zone, a national-level economic and technological development zone. The company is an innovative pharmaceutical enterprise integrating R&D, manufacturing, and sales, with business spanning pharmaceutical APIs and intermediates, veterinary APIs and intermediates, and CDMO services. It has established standardized and robust production and quality management systems, has successfully obtained U.S. FDA certification six consecutive times, and has secured Ministry of Agriculture GMP certification four consecutive times. Its products are exported to markets worldwide.
Honor Bio is a national high-tech enterprise, a specialized, refined, distinctive, and innovative SME in Zhejiang Province, and a science-and-technology-oriented SME in Zhejiang Province, boasting robust R&D capabilities and extensive experience in industrialization. The company has established national-level postdoctoral workstations and provincial-level enterprise research institutes as platforms for scientific research and talent development, and has forged industry–university–research collaboration partnerships with renowned domestic universities and research institutions, including the Chinese Academy of Sciences and Zhejiang University. Since its inception, the company has consistently placed talent at the core of its operations, building a high-tech R&D team centered on highly educated, professionally skilled personnel, including doctoral degree holders and professor-level senior engineers from both China and abroad. To date, the company has been granted more than 20 invention patents, including two international patents, and has received three national-level new-product awards and other significant scientific and technological achievements.
Looking ahead, Glory Bio will continue to uphold the pharmaceutical industry’s stringent standards and rigorous requirements, accelerate innovation in science and technology, and build itself into a globally oriented, innovation-driven pharmaceutical technology company. We remain steadfast in our commitment to developing and manufacturing high-quality pharmaceutical products, tirelessly striving to create a healthier future.